Index of /phmpt.org-march-01/pfizers-documents/
../
5.2-listing-of-clinical-sites-and-cvs-pages-1-4..> 13-Mar-2022 02:25 8399970
5.2-tabular-listing.pdf 13-Mar-2022 02:25 1803275
5.3.6-postmarketing-experience.pdf 13-Mar-2022 02:25 1007157
BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt 13-Mar-2022 02:25 9324
BATES-93_tv.xpt 13-Mar-2022 02:25 15920
BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov..> 13-Mar-2022 02:25 8705
BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev..> 13-Mar-2022 02:25 8725
BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev..> 13-Mar-2022 02:25 9324
BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt 13-Mar-2022 02:25 4643
BATES-FDA-CBER-2021-5683-0002376_relrec.xpt 13-Mar-2022 02:25 580240
BATES-FDA-CBER-2021-5683-0002377_supppr.xpt 13-Mar-2022 02:25 73520
BATES-FDA-CBER-2021-5683-0002378_ta.xpt 13-Mar-2022 02:25 8640
BATES-FDA-CBER-2021-5683-0002379_te.xpt 13-Mar-2022 02:25 3360
BATES-FDA-CBER-2021-5683-0002380_ti.xpt 13-Mar-2022 02:25 37840
CRFs-for-site-1055.pdf 13-Mar-2022 02:25 6728425
CRFs-for-site-1081.pdf 13-Mar-2022 02:25 13844325
CRFs-for-site-1096.pdf 13-Mar-2022 02:25 11824569
CRFs-for-site-1128.pdf 13-Mar-2022 02:25 14209495
Pages-42-289-Section-5.2-listing-clinical-sites..> 13-Mar-2022 02:25 12887950
Pages-42-289-Section-5.2-listing-clinical-sites..> 13-Mar-2022 02:26 14445688
STN-125742_0_0-Section-2.5-Clinical-Overview.pdf 13-Mar-2022 02:26 4403695
STN-125742_0_0-Section-2.7.3-Summary-of-Clinica..> 13-Mar-2022 02:26 3307888
STN-125742_0_0-Section-2.7.4-summary-clin-safet..> 13-Mar-2022 02:26 6812053
Supplemental-Index-12-22-21.pdf 13-Mar-2022 02:26 2034400
signed-F21-5683-CBER-Dec-13-2021-Response-Lette..> 13-Mar-2022 02:26 211533